Suppr超能文献

滑液中晶体分析:分析人员的培训可带来高度一致性。

Analysis for crystals in synovial fluid: training of the analysts results in high consistency.

作者信息

Lumbreras B, Pascual E, Frasquet J, González-Salinas J, Rodríguez E, Hernández-Aguado I

机构信息

Department of Clinical Analysis, Hospital General Universitario de Alicante, Spain.

出版信息

Ann Rheum Dis. 2005 Apr;64(4):612-5. doi: 10.1136/ard.2004.027268.

Abstract

BACKGROUND

Identification of monosodium urate (MSU) and calcium pyrophosphate dehydrate (CPPD) crystals in synovial fluid samples is diagnostic of gout and CPPD crystal related arthropathy. Various studies have shown poor consistency in results of crystal analysis.

OBJECTIVE

To determine whether training of the analysts increases the consistency.

METHODS

An expert rheumatologist gave a course on crystal detection and identification. The four trained observers then blindly and independently examined synovial fluid samples previously classified by the expert which had been obtained from patients with both crystal arthropathies and other non-crystal related inflammatory joint conditions.

RESULTS

194 observations were made on 64 synovial fluid samples: 96 without crystals (49.4%), 55 with CPPD crystal (28.4%), and 43 with MSU crystals (22.2%). For crystal detection (presence or absence of crystals), sensitivity was 95.9% and specificity 86.5%. For identification of MSU crystals, sensitivity was 95.3% and specificity 97.2%. For identification of CPPD crystals, sensitivity was 92.7% and specificity 92.1%. The kappa index of agreement with the reference standard between the observers was 0.84 for any crystal detection, 0.93 for MSU crystal sample identification, and 0.79 for CPPD crystal sample identification.

CONCLUSIONS

For trained observers, the detection and identification of crystals in synovial fluid is a consistent procedure.

摘要

背景

滑膜液样本中尿酸钠(MSU)和焦磷酸钙二水合物(CPPD)晶体的鉴定可诊断痛风和与CPPD晶体相关的关节病。多项研究表明晶体分析结果的一致性较差。

目的

确定分析人员的培训是否能提高一致性。

方法

一位专家级风湿病学家开设了晶体检测与鉴定课程。然后,四名经过培训的观察者对专家先前分类的滑膜液样本进行盲法独立检查,这些样本取自患有晶体关节病和其他非晶体相关炎性关节疾病的患者。

结果

对64个滑膜液样本进行了194次观察:96个无晶体(49.4%),55个有CPPD晶体(28.4%),43个有MSU晶体(22.2%)。对于晶体检测(有无晶体),敏感性为95.9%,特异性为86.5%。对于MSU晶体的鉴定,敏感性为95.3%,特异性为97.2%。对于CPPD晶体的鉴定,敏感性为92.7%,特异性为92.1%。观察者与参考标准之间的一致性kappa指数在任何晶体检测时为0.84,在MSU晶体样本鉴定时为0.93,在CPPD晶体样本鉴定时为0.79。

结论

对于经过培训的观察者,滑膜液中晶体的检测和鉴定是一个一致的过程。

相似文献

1
Analysis for crystals in synovial fluid: training of the analysts results in high consistency.
Ann Rheum Dis. 2005 Apr;64(4):612-5. doi: 10.1136/ard.2004.027268.
3
The added value of synovial fluid centrifugation for monosodium urate and calcium pyrophosphate crystal detection.
Clin Rheumatol. 2017 Jul;36(7):1599-1605. doi: 10.1007/s10067-017-3633-6. Epub 2017 Apr 19.
4
Synovial fluid analysis for crystals.
Curr Opin Rheumatol. 2011 Mar;23(2):161-9. doi: 10.1097/BOR.0b013e328343e458.
6
Synovial fluid analysis for the enhanced clinical diagnosis of crystal arthropathies in a tertiary care institution.
Clin Rheumatol. 2021 Aug;40(8):3239-3246. doi: 10.1007/s10067-021-05610-0. Epub 2021 Feb 17.
7
White blood cell count and total protein concentration to predict the absence of microcrystals in synovial fluid.
Clin Biochem. 2020 Sep;83:81-85. doi: 10.1016/j.clinbiochem.2020.05.010. Epub 2020 May 26.
8
Clinical implications of synovial fluid specimen handling for crystal associated arthritides: A systematic review.
Int J Rheum Dis. 2021 Jan;24(1):10-20. doi: 10.1111/1756-185X.14019. Epub 2020 Nov 5.
9
Most calcium pyrophosphate crystals appear as non-birefringent.
Ann Rheum Dis. 1999 Sep;58(9):582-4. doi: 10.1136/ard.58.9.582.

引用本文的文献

4
Development and validation of a self-updating gout register from electronic health records data.
RMD Open. 2024 Apr 24;10(2):e004120. doi: 10.1136/rmdopen-2024-004120.
6
A glance into the future of gout.
Ther Adv Musculoskelet Dis. 2022 Jul 28;14:1759720X221114098. doi: 10.1177/1759720X221114098. eCollection 2022.
7
X-ray dark-field radiography for in situ gout diagnosis by means of an ex vivo animal study.
Sci Rep. 2021 Sep 24;11(1):19021. doi: 10.1038/s41598-021-98151-0.
8
"Lessons from Rare Forms of Osteoarthritis".
Calcif Tissue Int. 2021 Sep;109(3):291-302. doi: 10.1007/s00223-021-00896-3. Epub 2021 Aug 21.
9
Calcium pyrophosphate crystal size and characteristics.
Osteoarthr Cartil Open. 2021 Mar;3(1). doi: 10.1016/j.ocarto.2020.100133. Epub 2021 Jan 6.
10
Identifying Potential Classification Criteria for Calcium Pyrophosphate Deposition Disease: Item Generation and Item Reduction.
Arthritis Care Res (Hoboken). 2022 Oct;74(10):1649-1658. doi: 10.1002/acr.24619. Epub 2022 Jun 30.

本文引用的文献

1
Identification of urate crystals in gouty synovial fluid.
Ann Intern Med. 1961 Mar;54:452-60. doi: 10.7326/0003-4819-54-3-452.
2
Diagnosis of crystal-induced arthritis by synovial fluid examination for crystals: lessons from an imperfect test.
Arthritis Care Res. 1999 Dec;12(6):376-80. doi: 10.1002/1529-0131(199912)12:6<376::aid-art5>3.0.co;2-5.
3
What is new about crystals other than monosodium urate?
Curr Opin Rheumatol. 2000 May;12(3):228-34. doi: 10.1097/00002281-200005000-00013.
4
Most calcium pyrophosphate crystals appear as non-birefringent.
Ann Rheum Dis. 1999 Sep;58(9):582-4. doi: 10.1136/ard.58.9.582.
5
Identification of crystals in synovial fluid.
Ann Rheum Dis. 1999 May;58(5):261-3. doi: 10.1136/ard.58.5.261.
6
Quality control of synovial fluid crystal identification.
Ann Rheum Dis. 1998 Feb;57(2):107-9. doi: 10.1136/ard.57.2.107.
8
The diagnosis of gout and CPPD crystal arthropathy.
Br J Rheumatol. 1996 Apr;35(4):306-8. doi: 10.1093/rheumatology/35.4.306.
9
Interobserver variation in the assessment of the sampling quality of cervical smears.
J Clin Epidemiol. 1993 Apr;46(4):367-70. doi: 10.1016/0895-4356(93)90151-p.
10
ABC of rheumatology. Gout, hyperuricaemia, and crystal arthritis.
BMJ. 1995 Feb 25;310(6978):521-4. doi: 10.1136/bmj.310.6978.521.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验